We are live on ! Find out more
DAM

DLD Asset Management Portfolio holdings

AUM $1.1B
1-Year Est. Return 4.68%
This Fund
S&P 500
This Quarter Est. Return
+0.72%
1 Year Est. Return
+4.68%
3 Year Est. Return
+8.24%
5 Year Est. Return
+32.95%
10 Year Est. Return
AUM
$1.98B
AUM Growth
-$426M
Cap. Flow
-$1.46B
Cap. Flow %
-73.78%
Top 10 Hldgs %
72.69%
Holding
122
New
35
Increased
10
Reduced
14
Closed
43

Sector Composition

1 Healthcare 5.18%
2 Consumer Discretionary 1.63%
3 Industrials 1.46%
4 Technology 0.94%
5 Communication Services 0.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GEN icon
26
Gen Digital
GEN
$16.1B
$4.02M 0.2%
+170,000
New +$3.97M
UA icon
27
Under Armour Class C
UA
$3.1B
$3.27M 0.17%
180,100
-160,000
-47% -$3.15M
PSDO
28
DELISTED
Presidio, Inc. Common Stock
PSDO
$3.21M 0.16%
+190,000
New +$2.83M
LTXB
29
DELISTED
LegacyTexas Financial Group Inc
LTXB
$3.03M 0.15%
69,634
+30,000
+76% +$1.25M
TGE
30
DELISTED
Tallgrass Energy, LP Class A Shares
TGE
$3.02M 0.15%
+150,000
New +$2.9M
TVRD
31
PUT
Tvardi Therapeutics
TVRD
$30M
$3.01M 0.15%
+4,581
New +$3.81M
DISCK
32
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$2.74M 0.14%
111,300
-135,100
-55% -$3.65M
W icon
33
PUT
Wayfair
W
$11.8B
$2.47M 0.12%
+22,000
New +$2.82M
SRPT icon
34
PUT
Sarepta Therapeutics
SRPT
$1.82B
$2.37M 0.12%
+31,500
New +$3.72M
ILMN icon
35
Illumina
ILMN
$28.2B
$2.19M 0.11%
+7,402
New +$2.18M
TDOC icon
36
Teladoc Health
TDOC
$1.7B
$2.1M 0.11%
+31,000
New +$2.04M
SIOX
37
CALL
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$2.03M 0.1%
+315,700
New +$2.18M
LBTYK icon
38
Liberty Global Class C
LBTYK
$3.41B
$2M 0.1%
+84,200
New +$2.19M
BKNG icon
39
PUT
Booking.com
BKNG
$141B
$1.96M 0.1%
25,000
BMRN icon
40
PUT
BioMarin Pharmaceuticals
BMRN
$11.5B
$1.82M 0.09%
27,000
+6,000
+29% +$462K
GOSS icon
41
CALL
Gossamer Bio
GOSS
$83.2M
$1.71M 0.09%
+102,000
New +$2.03M
AVTR.PRA
42
DELISTED
Avantor, Inc. Series A Mandatory Convertible Preferred Stock
AVTR.PRA
$1.6M 0.08%
30,000
FOMX
43
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$1.6M 0.08%
525,000
BMRN icon
44
BioMarin Pharmaceuticals
BMRN
$11.5B
$1.54M 0.08%
22,800
-4,500
-16% -$347K
ITCI
45
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$1.51M 0.08%
202,000
-950,900
-82% -$9.12M
HHH icon
46
Howard Hughes
HHH
$4.19B
$1.43M 0.07%
+11,539
New +$1.43M
ACAD icon
47
PUT
Acadia Pharmaceuticals
ACAD
$4.38B
$1.37M 0.07%
+38,100
New +$1.16M
WMGI
48
PUT
DELISTED
Wright Medical Group Inc
WMGI
$1.03M 0.05%
+50,000
New +$1.19M
CVRS
49
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
$939K 0.05%
+219,479
New +$796K
ENTX icon
50
Entera Bio
ENTX
$97.6M
$919K 0.05%
369,000
-442
-0.1% -$1.26K

Similar funds

DLD Asset Management's Q3 2019 Portfolio in Review

As of Q3 2019, DLD Asset Management held 122 positions worth $1.98B, down 18% from $2.4B the previous quarter. Its ten largest holdings account for 73% of the portfolio.

DLD Asset Management withdrew a net $1.46B in Q3 2019, closing 43 positions and reducing 14 holdings. Its most notable exit was L3 Technologies, Inc., an estimated $55.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 5.2% of assets, up from 3.5% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, DLD Asset Management opened a new position in Wellcare Health Plans, Inc. worth $20.7M.

  • DLD Asset Management's largest Q3 2019 buy was Wellcare Health Plans, Inc.: 80,000 shares worth $20.7M.
  • DLD Asset Management added most to Allergan plc in Q3 2019, an estimated $22.6M increase.
  • DLD Asset Management's biggest Q3 2019 reduction was SunTrust Banks, Inc., cutting an estimated $28.6M.
  • DLD Asset Management fully exited L3 Technologies, Inc. in Q3 2019, selling an estimated $55.4M.
  • DLD Asset Management's ten largest holdings make up 73% of its $1.98B portfolio in Q3 2019.
  • DLD Asset Management opened 35 new positions and closed 43 in Q3 2019.
  • DLD Asset Management's portfolio value fell 18% quarter-over-quarter to $1.98B.

Based on DLD Asset Management's 13F filing for Q3 2019, filed 12 Nov 2019.